UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

International clinical psychopharmacology, 2014-07, Vol.29 (4), p.185-196

2014

Volltextzugriff (PDF)

Depression with high levels of anxiety

International clinical psychopharmacology, 2019-05, Vol.34 (3), p.109

Montgomery, Stuart A

2019

Volltextzugriff (PDF)

Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

European neuropsychopharmacology, 2019-09, Vol.29 (9), p.971-985

2019

Volltextzugriff (PDF)

Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder

The journal of clinical psychiatry, 2016-03, Vol.77 (3), p.371-378

2016

Volltextzugriff (PDF)

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine

Human psychopharmacology, 2014-09, Vol.29 (5), p.470-482

2014

Volltextzugriff (PDF)

European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings

European neuropsychopharmacology, 2012-07, Vol.22 (7), p.453-468

2012

Volltextzugriff (PDF)

Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study

The journal of clinical psychiatry, 2009-04, Vol.70 (4), p.526-539

2009

Volltextzugriff (PDF)

Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study

The journal of clinical psychiatry, 2013-04, Vol.74 (4), p.363-369

2013

Volltextzugriff (PDF)

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

International clinical psychopharmacology, 2007-09, Vol.22 (5), p.283-291

2007

Volltextzugriff (PDF)

Antidepressant or antidepressant plus placebo effect?

World psychiatry, 2015-10, Vol.14 (3), p.303-304

Montgomery, Stuart A.

2015

Volltextzugriff (PDF)

Age as a moderating factor of treatment resistance in depression

European psychiatry, 2023-04, Vol.66 (1), p.e35-e35, Article e35

2023

Volltextzugriff (PDF)

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression

Progress in neuro-psychopharmacology & biological psychiatry, 2019-08, Vol.94, p.109638-109638, Article 109638

2019

Volltextzugriff (PDF)

Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis

International clinical psychopharmacology, 2017-01, Vol.32 (1), p.41-48

2017

Volltextzugriff (PDF)

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine

The journal of clinical psychiatry, 2006-05, Vol.67 (5), p.771-782

2006

Volltextzugriff (PDF)

Lack of Efficacy of the Substance P (Neurokinin 1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Biological psychiatry (1969), 2006-02, Vol.59 (3), p.216-223

2006

Volltextzugriff (PDF)

Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants

CNS spectrums, 2008-07, Vol.13 (7 Suppl 11), p.27-33

Montgomery, Stuart A

2008

Volltextzugriff (PDF)

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder

Journal of affective disorders, 2013-10, Vol.151 (1), p.209-219

2013

Volltextzugriff (PDF)

Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression

Current medicinal chemistry, 2021-01, Vol.28 (22), p.4296-4320

2021

Volltextzugriff (PDF)

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

International clinical psychopharmacology, 2009-05, Vol.24 (3), p.111-118

2009

Volltextzugriff (PDF)

Discontinuation symptoms in depression and anxiety disorders

The international journal of neuropsychopharmacology, 2007-02, Vol.10 (1), p.73-84

2007

Volltextzugriff (PDF)

Pregabalin for the treatment of generalised anxiety disorder

Expert opinion on pharmacotherapy, 2006-10, Vol.7 (15), p.2139-2154

Montgomery, Stuart A

2006

Volltextzugriff (PDF)

Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression

Journal of affective disorders, 2015-09, Vol.184, p.51-59

2015

Volltextzugriff (PDF)

Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control

International clinical psychopharmacology, 2013-01, Vol.28 (1), p.12-19

2013

Volltextzugriff (PDF)

Which antidepressants have demonstrated superior efficacy? A review of the evidence

International clinical psychopharmacology, 2007-11, Vol.22 (6), p.323-329

2007

Volltextzugriff (PDF)

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials

CNS spectrums, 2015-04, Vol.20 (2), p.148-156

2015

Volltextzugriff (PDF)

1 – 25 von 695

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(630)
Mit Volltextzugriff
(519)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(442)
Life Sciences & Biomedicine
(422)
Humans
(348)
Female
(198)
Male
(187)
Psychiatry
(185)
Middle Aged
(139)
Adult
(135)
Biological And Medical Sciences
(132)
Medical Sciences
(126)
Pharmacology & Pharmacy
(106)
Neurosciences & Neurology
(87)
Aged
(86)
Treatment Outcome
(86)
Depression
(83)
Clinical Neurology
(80)
Depressive Disorder, Major - Drug Therapy
(69)
Psychology. Psychoanalysis. Psychiatry
(69)
Antidepressive Agents - Therapeutic Use
(66)
Pharmacology. Drug Treatments
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

Depression with high levels of anxiety

Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder

A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine

European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings

Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study

Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

Antidepressant or antidepressant plus placebo effect?

Age as a moderating factor of treatment resistance in depression

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression

Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine

Lack of Efficacy of the Substance P (Neurokinin 1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder

Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

Discontinuation symptoms in depression and anxiety disorders

Pregabalin for the treatment of generalised anxiety disorder

Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression

Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials

Suchergebnisse filtern